Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
Thymulin (Zn-FTS) (ZNFTS) is a research peptide, at the preclinical stage in the published literature. Zinc-dependent thymic hormone essential for T-cell maturation. Declines significantly with age.
Zinc-dependent thymic hormone essential for T-cell maturation. Declines significantly with age.
| Research Status | Preclinical |
|---|---|
| Half-Life | Unknown |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | Research varies |
Requires zinc for activity, modulates T-cell development and immune function.
Zinc-dependent thymic hormone essential for T-cell maturation. Declines significantly with age.
Requires zinc for activity, modulates T-cell development and immune function.
Thymulin (Zn-FTS) is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.
Reported half-life: Unknown.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.